About Axonics
Axonics is a company based in Irvine (United States) founded in 2013 was acquired by Boston Scientific in January 2024.. Axonics has raised $143.47 million across 7 funding rounds from investors including Boston Scientific, SVB and Edmond de Rothschild. Axonics has completed 2 acquisitions, including Bulkamid and Contura. Axonics operates in a competitive market with competitors including Amber Therapeutics, NeuSpera Medical, UroMems, Signum Surgical and Averto Medical, among others.
- Headquarter Irvine, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$143.47 M (USD)
in 7 rounds
-
Latest Funding Round
$20 M (USD), Debt – Conventional
Apr 03, 2018
-
Investors
Boston Scientific
& 10 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Bulkamid
& 1 more
-
Acquired by
Boston Scientific
(Jan 08, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Axonics
Axonics has successfully raised a total of $143.47M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $20 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Debt – Conventional — $20.0M
-
First Round
First Round
(25 Mar 2014)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2018 | Amount | Series C - Axonics | Valuation | Longitude Capital | |
| Apr, 2018 | Amount | Debt – Conventional - Axonics | Valuation |
investors |
|
| Jul, 2017 | Amount | Series C - Axonics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Axonics
Axonics has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, SVB and Edmond de Rothschild. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life science sector
|
Founded Year | Domain | Location | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Founded Year | Domain | Location | |
|
Diversified asset management, corporate advisory, and private equity firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Axonics
Axonics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Bulkamid and Contura. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of the bulking agent for women urinary incontinence
|
2003 | ||||
|
Generic drugs and hydrogel products are manufactured by Contura.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Axonics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Axonics Comparisons
Competitors of Axonics
Axonics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amber Therapeutics, NeuSpera Medical, UroMems, Signum Surgical and Averto Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Bioelectrical therapies for peripheral nervous system disorders are developed.
|
|
| domain | founded_year | HQ Location |
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
|
|
| domain | founded_year | HQ Location |
Developer of active implantable devices for urological incontinence
|
|
| domain | founded_year | HQ Location |
Surgically implanted devices for perianal fistula treatment are provided.
|
|
| domain | founded_year | HQ Location |
Medical devices for gastrointestinal disease patients are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Axonics
Frequently Asked Questions about Axonics
When was Axonics founded?
Axonics was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Axonics located?
Axonics is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Who is the current CEO of Axonics?
Raymond W Cohen is the current CEO of Axonics.
Is Axonics a funded company?
Axonics is a funded company, having raised a total of $143.47M across 7 funding rounds to date. The company's 1st funding round was a Series C of $20.5M, raised on Mar 25, 2014.
What does Axonics do?
Axonics was founded in 2013 in Irvine, United States, within the medical device sector. Implantable neurostimulators are developed using sacral neuromodulation technology to address urinary and bowel dysfunctions. The system features a compact device with a helical-tined lead to minimize migration, implanted in the sacral area, and supported by a tablet-based programmer for clinical adjustments. Operations focus on innovation in neuromodulation for pelvic health management.
Who are the top competitors of Axonics?
Axonics's top competitors include NeuSpera Medical, Amber Therapeutics and UroMems.
How many acquisitions has Axonics made?
Who are Axonics's investors?
Axonics has 11 investors. Key investors include Boston Scientific, SVB, Edmond de Rothschild, Longitude Capital, and Gilde Healthcare.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.